-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Tasimelteon in Insomnia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tasimelteon in Insomnia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tasimelteon in Insomnia Drug Details: Tasimelteon (Hetlioz) is a derivative of benzofuran acts...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LB-54640 in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LB-54640 in Obesity report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LB-54640 in Obesity Drug Details: LB-54640 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VIC-1911 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VIC-1911 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.VIC-1911 in Non-Small Cell Lung Cancer Drug Details:VIC-1911 was under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Setmelanotide Hydrochloride Er in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Setmelanotide Hydrochloride Er in Obesity report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Setmelanotide Hydrochloride Er in Obesity Drug Details: Setmelanotide hydrochloride extended...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ruxolitinib Phosphate in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ruxolitinib Phosphate in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ruxolitinib Phosphate in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)...
-
Company Insights
Innovation and Patenting activity of Rhythm Pharmaceuticals Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Rhythm Pharmaceuticals Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
ECG Monitoring Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Electrocardiogram (ECG) Monitoring Equipment Pipeline Market Report Overview Electrocardiogram (ECG) Monitoring Equipment records the electrocardiogram (ECG) and is used to evaluate 10 seconds (or a specific time interval) of electrical activity of the heart so a physician can determine the condition of a patient's heart. The ECG Monitoring Equipment pipeline market research report provides comprehensive information about the ECG Monitoring Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials...
-
Company Profile
Rhythm Pharmaceuticals Inc – Company Profile
Rhythm Pharmaceuticals Inc (Rhythm Pharmaceuticals) is a commercial-stage biopharmaceutical company. It develops therapies for the treatment of rare genetic diseases of obesity due to pro-opiomelanocortin (POMC), proprotein convertase subtilisin and kexin type 1 (PCSK1) and leptin receptor (LEPR) deficiency. The company’s lead drug IMCIVREE (setmelanotide), is a precision medicine to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases. It is advancing RM-853, a ghrelin O-acyltransferase (GOAT) inhibitor targeting prader-willi syndrome. The company operates in the...
Add to Basket